676 related articles for article (PubMed ID: 18656187)
1. Treatment of experimental osteomyelitis by methicillin resistant Staphylococcus aureus with bone cement system releasing grepafloxacin.
Efstathopoulos N; Giamarellos-Bourboulis E; Kanellakopoulou K; Lazarettos I; Giannoudis P; Frangia K; Magnissalis E; Papadaki M; Nikolaou VS
Injury; 2008 Dec; 39(12):1384-90. PubMed ID: 18656187
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Joosten U; Joist A; Gosheger G; Liljenqvist U; Brandt B; von Eiff C
Biomaterials; 2005 Sep; 26(25):5251-8. PubMed ID: 15792552
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Yin LY; Calhoun JH; Thomas TS; Wirtz ED
J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
6. Treatment of long bone osteomyelitis with a mechanically stable intramedullar antibiotic dispenser: nineteen consecutive cases with a minimum of 12 months follow-up.
Sancineto CF; Barla JD
J Trauma; 2008 Dec; 65(6):1416-20. PubMed ID: 19077636
[TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis of the mandible.
Tuzuner-Oncul AM; Ungor C; Dede U; Kisnisci RS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):e1-4. PubMed ID: 19464635
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
[TBL] [Abstract][Full Text] [Related]
9. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit.
Giavaresi G; Borsari V; Fini M; Giardino R; Sambri V; Gaibani P; Soffiatti R
J Orthop Res; 2008 Jun; 26(6):785-92. PubMed ID: 18186130
[TBL] [Abstract][Full Text] [Related]
10. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
[TBL] [Abstract][Full Text] [Related]
11. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats.
Mendel V; Simanowski HJ; Scholz HC; Heymann H
Arch Orthop Trauma Surg; 2005 Jul; 125(6):363-8. PubMed ID: 15864679
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
[TBL] [Abstract][Full Text] [Related]
13. Experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus treated with a polylactide carrier releasing linezolid.
Tsiolis P; Giamarellos-Bourboulis EJ; Mavrogenis AF; Savvidou O; Lallos SN; Frangia K; Lazarettos I; Nikolaou V; Efstathopoulos NE
Surg Infect (Larchmt); 2011 Apr; 12(2):131-5. PubMed ID: 21348763
[TBL] [Abstract][Full Text] [Related]
14. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
15. Treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis with vancomycin-loaded VK100 silicone cement: An experimental study in rats.
Neyisci C; Erdem Y; Bilekli AB; Demiralp B; Kose O; Bek D; Korkusuz F; Kankilic B
J Orthop Surg (Hong Kong); 2018; 26(1):2309499017754093. PubMed ID: 29382296
[TBL] [Abstract][Full Text] [Related]
16. Novel model for studying hematogenous infection in an experimental setting of implant-related infection by a community-acquired methicillin-resistant S. aureus strain.
Poultsides LA; Papatheodorou LK; Karachalios TS; Khaldi L; Maniatis A; Petinaki E; Malizos KN
J Orthop Res; 2008 Oct; 26(10):1355-62. PubMed ID: 18425805
[TBL] [Abstract][Full Text] [Related]
17. In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model.
Faber C; Hoogendoorn RJ; Stallmann HP; Lyaruu DM; van Nieuw Amerongen A; Wuisman PI;
J Antimicrob Chemother; 2004 Dec; 54(6):1078-84. PubMed ID: 15537700
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin for methicillin-resistant Staphylococcus aureus infections of the spine.
Burdette SD
Spine J; 2009 Jun; 9(6):e5-8. PubMed ID: 19112049
[TBL] [Abstract][Full Text] [Related]
19. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Henry NK; Rouse MS; Whitesell AL; McConnell ME; Wilson WR
Am J Med; 1987 Apr; 82(4A):73-5. PubMed ID: 3578332
[TBL] [Abstract][Full Text] [Related]
20. A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.
Mistry S; Roy S; Maitra NJ; Kundu B; Chanda A; Datta S; Joy M
J Control Release; 2016 Oct; 239():169-81. PubMed ID: 27582374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
